Treatment of high-grade glioma with radiolabeled peptides

Methods

Volumn 55, Issue 3, 2011, Pages 223-229

  Waitz, Dietmar ^a   Putzer, Daniel ^a   Kostron, Herwig ^a   Virgolini, Irene Johanna ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Glioblastoma; High grade glioma; PRRT; Radiolabeled peptides; Treatment

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1 GLUTARIC ACID 4,7,10 TRIACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID OCTREOTIDE(3 TYROSINE 1 DEXTRO PHENYLALANINE); BISMUTH 213; DEXAMETHASONE; GALLIUM 68; GLYCOPROTEIN; INDIUM 111; IODINE 131; LANTREOTIDE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID Y 90; LUTETIUM 177; MANNITOL; MONOCLONAL ANTIBODY I 131; MONOCLONAL ANTIBODY Y 90; NEUROKININ DERIVATIVE; OCTREOTIDE(3 TYROSINE 1 DEXTRO PHENYLALANINE) 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID GA 68; OCTREOTIDE(3 TYROSINE 1 DEXTRO PHENYLALANINE) 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID IN 111; OCTREOTIDE(3 TYROSINE 1 DEXTRO PHENYLALANINE) 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID Y 90; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; YTTRIUM 90;

ACUTE TOXICITY; ARTICLE; BONE MARROW SUPPRESSION; BRAIN EDEMA; BRAIN TISSUE; BRAIN TUMOR; CANCER CELL; CANCER RECURRENCE; CORTICOSTEROID THERAPY; DOSIMETRY; DRUG BINDING; EXTERNAL BEAM RADIOTHERAPY; GLIOMA; HUMAN; ISOTOPE LABELING; KIDNEY FUNCTION; MENINGIOMA; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROENDOCRINE TUMOR; PATIENT SELECTION; PEPTIDE RECEPTOR RADIONUCLIDE THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SIDE EFFECT; VOMITING;

EID: 82955182173     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2011.09.004     Document Type: Review

References (42)

1. Kleihues P., Louis D.N., Scheithauer B.W., Rorke L.B., Reifenberger G., Burger P.C., et al. J. Neuropathol. Exp. Neurol. 2002, 61(3):215-225.
2. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., et al. N. Engl. J. Med. 2005, 352(10):987-996.
3. Kreth F.W., Berlis A., Spiropoulou V., Faist M., Scheremet R., Rossner R., et al. Cancer 1999, 86(10):2117-2123.
4. Widhalm G., Wolfsberger S., Minchev G., Woehrer A., Krssak M., Czech T., et al. Cancer 2010, 116(6):1545-1552.
5. Hutterer M., Knyazev P., Abate A., Reschke M., Maier H., Stefanova N., et al. Clin. Cancer Res. 2008, 14(1):130-138.
6. Kostron H. Methods Mol. Biol. 2010, 635:261-280.
7. Sanai N., Berger M.S. Neurosurgery 2008, 62(4):753-764.
8. Hochberg F.H., Pruitt A. Neurology 1980, 30(9):907-911.
9. Dirks P., Bernstein M., Muller P.J., Tucker W.S. Can. J. Surg. 1993, 36(3):271-275.
10. Harsh G.R., Levin V.A., Gutin P.H., Seager M., Silver P., Wilson C.B. Neurosurgery 1987, 21(5):615-621.
11. Herold-Mende C., Mueller M.M., Bonsanto M.M., Schmitt H.P., Kunze S., Steiner H.H. Int. J. Cancer 2002, 98(3):362-369.
12. Kneifel S., Cordier D., Good S., Ionescu M.C., Ghaffari A., Hofer S., et al. Clin. Cancer Res 2006, 12(12):3843-3850.
13. Held-Feindt J., Krisch B., Mentlein R. Brain Res. Mol. Brain Res. 1999, 64(1):101-107.
14. Reubi J.C., Waser B., Schmassmann A., Laissue J.A. Int. J. Cancer 1999, 81(3):376-386.
15. Riva P., Franceschi G., Riva N., Casi M., Santimaria M., Adamo M. Eur. J. Nucl. Med. 2000, 27(5):601-609.
16. Zalutsky M.R. Br. J. Cancer 2004, 90(8):1469-1473.
17. Merlo A., Hausmann O., Wasner M., Steiner P., Otte A., Jermann E., et al. Clin. Cancer Res. 1999, 5(5):1025-1033.
18. Otte A., Jermann E., Behe M., Goetze M., Bucher H.C., Roser H.W., et al. Eur. J. Nucl. Med. 1997, 24(7):792-795.
19. Gabriel M., Andergassen U., Putzer D., Kroiss A., Waitz D., Von G.E., et al. Q. J. Nucl. Med. Mol. Imaging 2010, 54(1):92-99.
20. Lamszus K., Meyerhof W., Westphal M. J. Neurooncol. 1997, 35(3):353-364.
21. Reubi J.C., Horisberger U., Lang W., Koper J.W., Braakman R., Lamberts S.W. Am. J. Pathol. 1989, 134(2):337-344.
22. Dutour A., Kumar U., Panetta R., Ouafik L., Fina F., Sasi R., et al. Int. J. Cancer 1998, 76(5):620-627.
23. Kwekkeboom D.J., Mueller-Brand J., Paganelli G., Anthony L.B., Pauwels S., Kvols L.K., et al. J. Nucl. Med. 2005, 46(Suppl. 1):62S-66S.
24. Virgolini I., Traub T., Novotny C., Leimer M., Fuger B., Li S.R., et al. Curr. Pharm. Des. 2002, 8(20):1781-1807.
25. Hennig I.M., Laissue J.A., Horisberger U., Reubi J.C. Int. J. Cancer 1995, 61(6):786-792.
26. de Jong M., Breeman W.A., Kwekkeboom D.J., Valkema R., Krenning E.P. Acc. Chem. Res. 2009, 42(7):873-880.
27. Gabriel M., Decristoforo C., Kendler D., Dobrozemsky G., Heute D., Uprimny C., et al. J. Nucl. Med. 2007, 48(4):508-518.
28. Hockaday D.C., Shen S., Fiveash J., Raubitschek A., Colcher D., Liu A., et al. J. Nucl. Med. 2005, 46(4):580-586.
29. Gabriel M., Oberauer A., Dobrozemsky G., Decristoforo C., Putzer D., Kendler D., et al. J. Nucl. Med. 2009, 50(9):1427-1434.
30. Ferrari M., Cremonesi M., Bartolomei M., Bodei L., Chinol M., Fiorenza M., et al. J. Nucl. Med. 2006, 47(1):105-112.
31. Brans B., Bodei L., Giammarile F., Linden O., Luster M., Oyen W.J., et al. Eur. J. Nucl. Med. Mol. Imaging 2007, 34(5):772-786.
32. Kneifel S., Bernhardt P., Uusijarvi H., Good S., Plasswilm L., Buitrago-Tellez C., et al. Eur. J. Nucl. Med. Mol. Imaging 2007, 34(9):1388-1395.
33. Virgolini I., Britton K., Buscombe J., Moncayo R., Paganelli G., Riva P. Semin. Nucl. Med. 2002, 32(2):148-155.
34. Schumacher T., Hofer S., Eichhorn K., Wasner M., Zimmerer S., Freitag P., et al. Eur. J. Nucl. Med. Mol. Imaging 2002, 29(4):486-493.
35. Heute D., Kostron H., Von G.E., Ingorokva S., Gabriel M., Dobrozemsky G., et al. J. Nucl. Med. 2010, 51(3):397-400.
36. Bartolomei M., Bodei L., De C.C., Grana C.M., Cremonesi M., Botteri E., et al. Eur. J. Nucl. Med. Mol. Imaging 2009, 36(9):1407-1416.
37. van Essen M., Krenning E.P., Kooij P.P., Bakker W.H., Feelders R.A., de Herder W.W., et al. J. Nucl. Med. 2006, 47(10):1599-1606.
38. Cordier D., Forrer F., Bruchertseifer F., Morgenstern A., Apostolidis C., Good S., et al. Eur. J. Nucl. Med. Mol. Imaging 2010, 37(7):1335-1344.
39. Cordier D., Forrer F., Kneifel S., Sailer M., Mariani L., Macke H., et al. J. Neurooncol. 2010, 100(1):129-136.
40. Akabani G., Reardon D.A., Coleman R.E., Wong T.Z., Metzler S.D., Bowsher J.E., et al. J. Nucl. Med. 2005, 46(6):1042-1051.
41. Cervera P., Videau C., Viollet C., Petrucci C., Lacombe J., Winsky-Sommerer R., et al. J. Neuroendocrinol. 2002, 14(6):458-471.
42. Reubi J.C., Lang W., Maurer R., Koper J.W., Lamberts S.W. Cancer Res. 1987, 47(21):5758-5764.